Alpha Profiles · Company Profile

BICYCLE THERAPEUTICS PLC

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/bicycle-therapeutics-plc

Entity: Public listing published
Primary listing: NASDAQ: BCYC
Verification: Partially verified
Last reviewed: 2026-10-16T13:52:50.363049+00:00

Overview

Alpha's canonical identity and public leadership record for BICYCLE THERAPEUTICS PLC.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

6 public records

Alistair Milnes

Chief Corporate Development Officer

State: confirmed
Effective: From Apr 22, 2026
Confidence: 94%
Evidence: BCYC DEF 14A executive officersApr 22, 2026

Jennifer Perry, Pharm.D.

Chief Operating Officer

State: confirmed
Effective: From Apr 22, 2026
Confidence: 94%
Evidence: BCYC DEF 14A executive officersApr 22, 2026

Kevin Lee, Ph.D., MBA

Chief Executive Officer and Director

State: confirmed
Effective: From Apr 22, 2026
Confidence: 94%
Evidence: BCYC DEF 14A executive officersApr 22, 2026

Michael Hannay, D.Sc.

Chief Product and Supply Chain Officer

State: confirmed
Effective: From Apr 22, 2026
Confidence: 94%
Evidence: BCYC DEF 14A executive officersApr 22, 2026

Michael Skynner, Ph.D.

Chief Scientific Officer

State: confirmed
Effective: From Apr 22, 2026
Confidence: 94%
Evidence: BCYC DEF 14A executive officersApr 22, 2026

Travis Thompson

Chief Financial Officer

State: confirmed
Effective: From Apr 22, 2026
Confidence: 94%
Evidence: BCYC DEF 14A executive officersApr 22, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 16, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.